CDK inhibitor E9

• Description :

  CDK inhibitor E9 is a novel CDK inhibitor that can overcomes ABC-mediated resistance of THZ1, functions as a potent, non-covalent inhibitor of CDK9 and a covalent inhibitor of CDK12.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  434.544

• Molecular Formula :

  C24H30N6O2

• Notes :

  Research use only, not for human use.

• Receptor :

  CDK

• CAS Number :

  2020052-55-3